Multi+ is a dietary supplement, not a GLP-1 medication, and it does not replace a varied diet, adequate protein, fiber, fluids, or individualized medical care
Ethics approval and consent to participate This review synthesizes previously published scientific studies and does not include any experiments involving human subjects, animals, or the acquisition of new clinical information
Excessive loss of lean mass is an important issue, especially in an older population, and must be in the forefront of approaches to develop better drugs for chronic weight management and chronic disease management
Independent testing eliminates any conflict of interest in quality assessment
F.YanJ.et al (2017)
These medications slow gastric emptying, which could potentially influence taste perception through complex physiological pathways